Champions Oncology outlines fiscal 2027 plan with Corellia fully funded as it reports $59.4M revenue and $1.6M adjusted EBITDA (NASDAQ:CSBR)July 27, 2026
Share Facebook Twitter LinkedIn Pinterest Email Shares of Repay (RPAY) climbed over 4% today after the company reported solid Q3 results last night. Indeed, driven by new client signings and the continued ramp of […]
